SAXENA NISHANT C (Chief Business Officer) purchased 3.5% of their position (2.60K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $25.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2026ACC: 0001193125-26-346966
Officer· Chief Business Officer
Since May 2026
+2.60K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.60K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+2.60K
Price / share
$9.63
Trade value
$25.04K
% of position
3.5%
8/11/2026
75.30K→77.90K
Total
Net shares
+2.60K
Net value
$25.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 8/11/2026 | P · Purchase | +2.60K | $9.63 | $25.04K | 3.5% | 75.30K | 77.90K |
| Total | +2.60K | $25.04K | ||||||
Derivative Transactions0
No derivative transactions reported